FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:86-87 January 2, 2003 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Linezolid is an oxazolidinone antibiotic used to treat a variety of gram-positive infections, including those due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, as well as nocardia species.^1,2 Lactic acidosis is an adverse effect that has been associated with other drugs, including metformin and the nucleoside reverse-transcriptase inhibitors,³ but not with linezolid. We report a case in which severe lactic acidosis developed as an adverse effect of linezolid treatment.

A 52-year-old woman presented with fever, chills, and a two-week history of intermittent cough. Computed tomography (CT) of her chest revealed an infiltrate in the right middle lobe, . . . [Full Text of this Article]

This article has been cited by other articles:

• Garrabou, G., Soriano, A., Lopez, S., Guallar, J. P., Giralt, M., Villarroya, F., Martinez, J. A., Casademont, J., Cardellach, F., Mensa, J., Miro, OÒs. (2007). Reversible Inhibition of Mitochondrial Protein Synthesis during Linezolid-Related Hyperlactatemia. Antimicrob. Agents Chemother. 51: 962-967 [Abstract] [Full Text]  
• Duewelhenke, N., Krut, O., Eysel, P. (2007). Influence on Mitochondria and Cytotoxicity of Different Antibiotics Administered in High Concentrations on Primary Human Osteoblasts and Cell Lines. Antimicrob. Agents Chemother. 51: 54-63 [Abstract] [Full Text]  
• McKee, E. E., Ferguson, M., Bentley, A. T., Marks, T. A. (2006). Inhibition of Mammalian mitochondrial protein synthesis by oxazolidinones.. Antimicrob. Agents Chemother. 50: 2042-2049 [Abstract] [Full Text]  
• Bishop, E., Melvani, S., Howden, B. P., Charles, P. G. P., Grayson, M. L. (2006). Good Clinical Outcomes but High Rates of Adverse Reactions during Linezolid Therapy for Serious Infections: a Proposed Protocol for Monitoring Therapy in Complex Patients.. Antimicrob. Agents Chemother. 50: 1599-1602 [Abstract] [Full Text]  
• Soriano, A., Miro, O., Mensa, J. (2005). Mitochondrial Toxicity Associated with Linezolid.. NEJM 353: 2305-2306 [Full Text]  
• Fall, P. J., Szerlip, H. M. (2005). Lactic Acidosis: From Sour Milk to Septic Shock. J Intensive Care Med 20: 255-271 [Abstract]  
• Fortun, J., Martin-Davila, P., Navas, E., Perez-Elias, M. J., Cobo, J., Tato, M., De la Pedrosa, E. G.-G., Gomez-Mampaso, E., Moreno, S. (2005). Linezolid for the treatment of multidrug-resistant tuberculosis. J Antimicrob Chemother 56: 180-185 [Abstract] [Full Text]  
• (2003). A Patient with Refractory Disseminated Mycobacterium Avium After Immune-Reconstitution Localized MAC. AIDS Clin Care 2003: 2-2 [Full Text]